Change of opinion on the use of hydroxychloroquine for COVID-19 treatment and prevention
The use of hydroxychloroquine for COVID-19 treatment and prevention should be restricted in both out- and inpatient settings due to the lack of evidence for effectiveness and unfavorable safety profile.
Shranjeno v:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
Izdatelstvo OKI
2020-10-01
|
| Serija: | Качественная клиническая практика |
| Teme: | |
| Online dostop: | https://www.clinvest.ru/jour/article/view/535 |
| Oznake: |
Brez oznak, prvi označite!
|